No doubt they have they worst PR imaginable. They couldn't even spin this more positively.
Quite simply they need a partner. They obviously don't need the funding for the pre-clinical studies and Cohort 4 data will be released this year so there may be enough data for a partner.
Like ANP it now has an enterprise value of zero. The value of my holdings in these respective companies is now also about zero. BLT valued at 16mil. ANP $8mil.
